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Abstract
Despite recent evidences suggesting that agents inducing endoplasmic reticulum (ER) stress could
be exploited as potential antitumor drugs in combination with tumor necrosis factor-related
apoptosis-inducing ligand (TRAIL), the mechanisms of this anticancer action are not fully
understood. Moreover, the effects of ER stress and TRAIL in nontransformed cells remain to be
investigated. In this study we report that ER stress-inducing agents sensitizes both transformed
and nontransformed cells to TRAIL-induced apoptosis. In addition, glucose-regulated protein of
78 kDa (GRP78) knockdown by RNA interference induces ER stress and facilitates apoptosis by
TRAIL. We demonstrate that TRAIL death-inducing signaling complex (DISC) formation and
early signaling are enhanced in ER stressed cells. ER stress alters the cellular levels of different
apoptosis-related proteins including a decline in the levels of FLIP and Mcl-1 and the up-
regulation of TRAIL-R2. Up-regulation of TRAIL-R2 following ER stress is dependent on the
expression of PKR-like ER kinase (PERK) and independent of CAAT/enhancer binding protein
homologous protein (CHOP) and Ire1α. Silencing of TRAIL-R2 expression by siRNA blocks the
ER stress-mediated sensitization to TRAIL-induced apoptosis. Furthermore, simultaneous
silencing of cFLIP and Mcl-1 expression by RNA interference results in a marked sensitization to
TRAIL-induced apoptosis. Finally, in FLIP-overexpressing cells ER stress-induced sensitization
to TRAIL-activated apoptosis is markedly reduced. In summary, our data reveal a pleiotropic
mechanism involving both apoptotic and anti-apoptotic proteins for the sensitizing effect of ER
stress on the regulation of TRAIL receptor-mediated apoptosis in both transformed and non-
transformed cells.
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Introduction
TRAIL/Apo2L is a cytokine of the tumor necrosis factor (TNF) gene superfamily that
selectively induces apoptosis in many tumor cells while leaving normal cells intact and thus
is an attractive candidate for antitumor therapies [1]. TRAIL induces apoptosis through its
binding to membrane bound death domain (DD)-containing receptors TRAIL-R1/DR4 and
TRAIL-R2/DR5. This interaction induces the recruitment of the intracellular adaptor
molecule FADD (FAS-associated death domain protein), that concurrently engages
procaspase-8 at the death-inducing signaling protein complex (DISC) [2]. Within the DISC,
caspase-8 is activated by transcatalytic and autocatalytic cleavage and released into the
cytoplasm, initiating the protease cascade that leads to the effector caspases activation,
thereby triggering the execution of steps that induce apoptosis (extrinsic apoptotic pathway).
In addition, activated cas-pase-8 is able to cleave Bid, a BH3-only proapoptotic member of
the Bcl-2 family protein, releasing a truncated protein (tBid) that translocates to the
mitochondrial external membrane and, in concert with other proapoptotic Bcl-2 family
proteins, as Bax and Bak, induces the release of apoptogenic factors, thereby amplifying
caspase activation [3]. The apoptotic signal from the DISC may be inhibited by the cellular
FLICE-inhibitory protein (FLIP) [4]. In most cells, two alternatively spliced isoforms of
cFLIP exist: a caspase-8 homologue cFLIPL that lacks the amino acids critical for
proteolytic caspase activity; and cFLIPS, which is comprised of the two death effector
domains alone [4]. Although the role of cFLIP in apoptotic signaling remains controversial,
there is strong evidence that it displays antiapoptotic activity [5–7]. Despite the ubiquitous
expression of TRAIL receptors, some tumor cells, including most breast cancer cells, show
either partial or complete resistance to the apoptotic effects of TRAIL [8, 9]. To overcome
this resistance, TRAIL-induced signaling is being studied alone or in combination with
different sensitizing agents, such as chemotherapeutic drugs, cytokines and inhibitors of
survival pathways [10–12].
The ER is a central cellular organelle that is responsible for the folding and maturation of
most secreted and transmembrane proteins. In response to different environmental and
physiological stress conditions that increase the load of unfolded proteins in the ER, protein
sensors located in the luminal face of the ER membrane activate an intracellular signaling
mechanism called the unfolded protein response (UPR) to enhance the expression of ER-
resident chaperones [13]. Moreover, insufficient vascularization of solid tumors and the
increased production of immunoglobulins in multiple myeloma cells are conditions that
activate the UPR, to promote tumor survival and progression [14]. Furthermore, UPR
activation in tumor cells has been shown to induce apoptosis, at least in part, through
enhancing TRAIL-R2 expression [15–17]. Interestingly, ER stress and UPR activation
sensitize tumor cells to exogenous TRAIL-induced apoptosis, although the molecular
mechanism of this synergistic action remains unclear [18–20]. In addition, a cross-talk
between the UPR and the TRAIL system has been reported. Thus, activation of TRAIL
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receptors induces the translocation of pro-apoptotic Par-4/GRP78 complex to the cell
surface of tumor cells [17]. However, it is unknown whether ER stress has any impact on the
sensitivity of nontransformed cells to TRAIL. We hereby report that UPR activation
sensitizes both nontransformed and transformed cells to TRAIL-induced apoptosis. We also
demonstrate that GRP78 plays a survival role in TRAIL-induced apoptosis because GRP78
knockdown by siRNA induces ER stress and markedly sensitizes cells to TRAIL.
Furthermore, we show that ER stress up-regulates TRAIL-R2 expression through a PERK-
dependent, CHOP and Ire1α-independent mechanism. Finally, we demonstrate that anti-
apoptotic FLIP and Mcl-1 proteins are down-regulated in cells undergoing ER-stress and
this contribute to the sensitization observed to TRAIL.
Materials and methods
Cell culture and reagents
Soluble human His-tagged recombinant TRAIL (residues 95–281) was produced as
described [21]. Tunicamycin and thapsigargin were purchased from Sigma Chemical Corp
(St. Louis, MO). zVAD-fmk was from Bachem AG (Bachem, Bubendorf, Switzerland). The
human breast epithelial cell line MCF-10A was maintained in DMEM/F12 supplemented
with 5% donor horse serum, 2 mM L-glutamine, 20 ng/ml epidermal growth factor (EGF),
10 μg/ml insulin, 100 ng/ml cholera toxin/ml, 0.5 μg/ml hydrocortisone, 50 U/ml penicillin,
and 50 μg/ml streptomycin. The human hTERT-immortalized retinal pigment epithelial cell
line hTERT RPE-1 was grown in DMEM/F12 medium with 10% foetal bovine serum, 2
mM glutamine and antibiotics. The human tumor cell lines MDA-MB231 (breast), MDA-
MB231FLIPL [22], HeLa (cervix) and MM1s (multiple myeloma) were cultured in RPMI
medium containing 10% foetal bovine serum, 2 mM glutamine and antibiotics. All cell lines
were maintained at 37°C in a humidified 5% CO2, 95% air incubator.
Analysis of cell surface proteins by flow cytometry
Cells were detached from the culture dish with RPMI 1640 medium containing 3 mM
EDTA and cytofluorimetric analysis of proteins was performed as described [22] using the
CellQuest software (Becton–Dickinson, Mountain View, CA). Anti-TRAIL-R2 antibody
was from Abcam (Cambridge, UK). FITC-conjugated affinity-purified rabbit anti-mouse
immunoglobulins was purchased from DAKO (Glostrup, Denmark).
Isolation of the TRAIL DISC
DISC precipitation was performed using biotin-tagged recombinant TRAIL (bio-TRAIL)
[21]. Cells were incubated for 15 h in the presence or absence of tunicamycin as indicated in
the figure legend. After this incubation, cells were treated with bio-TRAIL for 30 min. DISC
formation was determined as reported [12].
RNA interference
siRNAs against Bid (5′-GAAGACAUCAUCCGGAAUAdT dT-3′), TRAIL-R1 (5′-
CACCAAUGCUUCCAACAAUdTd T-3′), TRAIL-R2 (5′-
GACCCUUGUGCUCGUUGUCdTd T-3′), GRP78 (5′-
GGAGCGCAUUGAUUGAUACUAGA dTdT-3′), CHOP
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(5′AAGAACCAGCAGAGGUCACAAd TdT-3′), Ire1alpha
(5′GCGUCUUUUACUACGUAAUdTd T-3′), PERK (5′
CAAACUGUAUAACGGUUUAdTdT-3′) and a scrambled control (5′-
GAGCGCUAGACAAUGAAGd TdT-3′) were from SIGMA-Proligo (Boulder, CO). Cells
were transfected with siRNAs using DharmaFECT 1 (Dharmacon, Lafayette, CO) as
described by the manufacturer.
Reverse transcriptase-polymerase chain reaction (RT-PCR)
Total RNA was isolated from cells with Trizol reagent (Life Technologies, Inc.) as
recommended by the supplier. cDNAs were synthesized from 2 μg of total RNA using a RT-
PCR kit (PerkinElmer Life Sciences) with the supplied oligo(dT) primer under conditions
described by the manufacturer. PCR reactions were performed using the following primers:
XBP1s (forward, 5′CCTTGTAGTTGAGA CCCAGG-3′; reverse, 5′-
GGGCTTGGTATATATGTG G-3′), CHOP (forward, 5′-GGTGGCAGCGCGACA
GACCAAAAAT-3′; reverse 5′-TCCAAGCCTTCCCCCT GCGTA-3′), TRAIL-R2
(forward, 5′-GCCTCATGGACA ATGAGATAAAGGTGGCT-3′; reverse, 5′-CCAAACT
CAAAGTACGCACAAACGG-3′). PCR cycle conditions were 95°C for 5 min followed
either by 30 cycles of 95°C for 45 s, 55°C for 30 s, and 72°C for 30 s (CHOP) or 94°C for 1
min, 55°C for 1 min, and 72°C for 1 min for 30 cycles (TRAIL-R2). XBP1s mRNA was
measured as described [23].
Analysis of apoptosis
Cells (5 × 105/well) were treated in 6-well plates as indicated in the figure legends. After
treatment, hypodiploid apoptotic cells were detected by flow cytometry according to
published procedures [24]. Briefly, cells were washed with phosphate buffered saline (PBS),
fixed in cold 70% ethanol and then stained with propidium iodide while treating with
RNAse. Quantitative analysis of cell cycle and hypodiploid cells was carried out in a
FACSCalibur cytometer using the Cell Quest software (Becton–Dickinson, Mountain View,
CA).
Chromatin condensation and fragmentation in apoptotic cells was assessed after staining of
cellular DNA with DAPI by viewing the cell preparations under a Leica fluorescent
microscope.
Immunoblot analysis of proteins
Proteins were resolved on SDS–polyacrylamide minigels and detected as described
previously [12]. The following antibodies were used in our studies: anti-FLIP monoclonal
antibody NF6 from Alexis Corp. (San Diego, CA), anti-caspase-8 generously provided by
Dr. Gerald Cohen (Leicester University, UK), anti-FADD obtained from BD Bioscience
(Erembodegem, Belgium), anti-GAPDH, myeloid cell leukemia-1 (Mcl-1), CHOP and
GRP78 were from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA), anti-Bid, a kind
donation of Dr. X Wang (Howard Hughes Institute, Dallas, Texas), antibodies against
TRAIL-R1/DR4, and TRAIL-R2/DR5 from R&D Systems (Minneapolis, USA), Ire1α, p-
eIF2α and anti-cleaved caspase-3 were from Cell Signaling (MA, USA), anti-caspase-9
monoclonal antibody was purchased from MBL International, Woburn, MA) and poly(ADP-
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ribose) polymerase (PARP) monoclonal antibody was from Roche Molecular Biochemicals
(Monza, Italy).
Statistical analysis
All data are presented as the mean ± SD of at least three independent experiments. The
differences among different groups were determined by the Student’s t test. P value <0.05
was considered significant.
Results
ER stress sensitizes both transformed and nontransformed cells to TRAIL-induced
apoptosis
It has been suggested that agents that induce ER stress may increase the therapeutic response
to TRAIL in tumor cells [18–20]. However, little is known about the impact that ER stress
may have on the sensitivity to TRAIL in nontransformed cells. Hereby, we have addressed
this issue by studying the effect of ER stress in the apoptotic response to TRAIL of different
transformed and nontransformed cell lines. To examine the effect of ER stress on the
apoptotic response to TRAIL, the breast cancer cell line MDA-MB231 was treated with
different concentrations of tunicamycin to determine the sub-toxic dose capable of
sensitizing these cells to TRAIL-induced apoptosis (Fig. 1a). Tunicamycin at doses between
25 and 500 ng/ml markedly sensitized MDA-MB231 cells to TRAIL. Lower panels show
chromatin condensation and fragmentation only in cells treated with tunicamycin (15 h)
followed by incubation in the presence of TRAIL (6 h). To further substantiate these
observations we also determined the effect of the ER calcium pump inhibitor thapsigargin, a
well known ER stress inducer, in the sensitivity of cancer cells to TRAIL. Treatment of
MDA-MB231 cells with the ER calcium pump inhibitor thapsigargin clearly sensitized
MDA-MB231 cells to the apoptotic action of TRAIL (Fig. 1a). Strikingly, the dose–
response of the various ER stress inducers in the sensitization of cells to TRAIL-induced
apoptosis closely correlated with the activation of the UPR as determined by the induction
of the CCAAT/enhancer binding protein homologous protein (CHOP) as well as formation
of the spliced mRNA form of the X-box binding protein-1 (XBP-1) XBP-1s (Fig. 1b).
Subsequently, other cancer cell lines of different origin were tested to determine whether
similar doses of tunicamycin also induced sensitization to TRAIL-induced apoptosis (Fig.
1c). In cervical carcinoma HeLa and multiple myeloma MM.1S cells, tunicamycin alone
induced little cell death at the concentration indicated. However, if the cells were exposed to
tunicamycin for 15 h before adding TRAIL, apoptotic cell death was markedly increased in
both cancer cell lines. Caspase activation was required for the sensitization observed as the
pan-caspase inhibitor Z-VAD-fmk completely abrogated the cell death induced by the
combination of tunicamycin and TRAIL (Fig. 1d). We also investigated the effect of ER
stress in the sensitivity of nontransformed cells to TRAIL. Breast (MCF10A) and retinal
pigment (hTERT-RPE1) epithelial cells lines were treated with tunicamycin prior to the
addition of TRAIL and apoptosis was determined. Results shown in Fig. 1e and f clearly
indicate that tunicamycin activated the UPR and markedly promoted TRAIL-induced
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apoptosis in these cells. Collectively, these results demonstrated that the ER is a key
regulator of the sensitivity of both transformed and nontransformed cells to TRAIL.
ER stress promotes TRAIL-induced activation of the mitochondrial apoptotic pathway
To further establish the mechanism of ER stress-promoted, TRAIL-induced apoptosis, we
examined caspases activation during this cell death process. In TRAIL-induced apoptosis,
procaspase-8 is recruited and processed at the DISC in a FADD- and TRAIL receptor-
dependent manner. Procaspase-8 is first cleaved to the p43/41 intermediate fragments
releasing the small subunit, p12, and then subsequently processed to generate the large
catalytically active p18 subunit. To test if caspase-8 activation by TRAIL was blocked in the
TRAIL resistant cell line MDA-MB231, processing of procaspase-8 was determined by
western blotting in cells treated with TRAIL following ER stress. As shown in Fig. 2a,
TRAIL-induced processing of procaspase-8 to its 43–41 kDa intermediate fragments was
observed only in the cells previously treated with tunicamycin. Furthermore, full processing
of caspase-8 to generate the p18 mature subunit only took place in ER stressed cells treated
with TRAIL.
Activation of caspase-8 leads to the processing of its substrate Bid generating a 15 kDa
fragment which translocates to mitochondria. Thus, we examined the activation of the
mitochondria-controlled apoptotic pathway by TRAIL in tunicamycin-treated cells by
determining the loss of intact Bid and the generation of truncated Bid (tBid). Results shown
in Fig. 2a indicate that the amount of intact Bid was clearly diminished in the cells treated
with tunicamycin and TRAIL in comparison with the cultures treated only with TRAIL or
tunicamycin. Accordingly, formation of tBid was only observed in cells treated with
tunicamycin and TRAIL. Similarly, caspase-9 and caspase-3 processing were also
stimulated by TRAIL in ER stressed cells (Fig. 2a). In contrast, in the absence of
tunicamycin, processing of caspases was barely detected. To further confirm that the
apoptosis cascade was fully active in MDA-MB231 cells treated with both tunicamycin and
TRAIL, we analyzed the processing of the nuclear protein PARP, a substrate of executioner
caspases. As shown in Fig. 2a, PARP cleavage was only induced in cells pre-treated with
tunicamycin and subsequently treated with TRAIL.
Ligation of pro-apoptotic TRAIL receptors by their ligand activates both mitochondria-
dependent and independent mechanisms of apoptosis in various cell types [25, 26]. We then
asked whether apoptosis induced by TRAIL in ER stressed cells required the activation of a
mitochondria-operated pathway. For this purpose, we silenced the expression of the BH3-
only protein Bid, a protein substrate of caspase-8 involved in the mitochondrial pathway
activated by death receptors and determined apoptosis in MDA-MB231 cells treated with
tunicamycin and TRAIL. Results shown in Fig. 2b demonstrate that Bid is at least partially
involved in the apoptosis induced by ER stress and TRAIL which suggested a certain role of
the mitochondria in this apoptotic pathway.
ER stress facilitates TRAIL DISC formation
In MDA-MB231 cells resistance to TRAIL occurred at a step prior to caspase-8 activation
(Fig. 2a). In non-stressed cells, TRAIL induced the formation of a death-inducing signaling
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complex (DISC) with recruitment of procaspase-8 and FADD to the TRAIL-R2 (Fig. 2c).
Caspase-8 processing to its p43/41 kDa forms was also observed at 30 min after TRAIL
addition. Interestingly, ER stress clearly enhanced TRAIL DISC formation, as indicated by
the higher amounts of TRAIL-R2, procaspase-8 and FADD in the DISC. Most importantly,
in ER stressed cells but not in control cells, activation of procaspase-8 processing at the
DISC following TRAIL addition proceeded to completion at 30 min upon TRAIL
stimulation (Fig. 2c).
CHOP and Ire1α-independent, PERK-dependent up-regulation of TRAIL-R2 is involved in
sensitization to TRAIL-induced apoptosis by ER stress
It has been reported that ER stress induces the expression of TRAIL-R2/DR5 [15, 16]. To
elucidate the mechanism of the sensitization to TRAIL observed in our studies following ER
stress, we first determined the expression of proapoptotic TRAIL-R2 in MDA-MB231 cells
subjected to ER stress inducers. In these experiments, tunicamycin and thapsigargin induced
a dose-dependent up-regulation of TRAIL-R2 protein and mRNA expression as measured
by western blot and RT-PCR analysis, respectively (Fig. 3a, b). Strikingly, the dose–
response relationship of TRAIL-R2 increase in ER stressed cells closely correlated with the
sensitization data (Fig. 1a). Importantly, ER stress also induced TRAIL-R2 up-regulation in
nontransformed cells (Fig. 3c). Moreover, ER stress-mediated increase in TRAIL-R2
expression was also observed at the cell surface, in both transformed and nontransformed
cells (Fig. 3d). Next, we examined the importance of TRAIL-R2 up-regulation in the
sensitization to TRAIL by silencing TRAIL-R2 expression with a siRNA duplex specific for
TRAIL-R2 mRNA prior to ER stress. Results of Fig. 4a demonstrate that TRAIL-R2 siRNA
efficiently down-regulated TRAIL-R2 protein expression and prevented TRAIL-R2 increase
by tunicamycin. Interestingly, apoptosis induced by the combination of tunicamycin and
TRAIL was completely prevented in cells transfected with siRNA to TRAIL-R2 (Fig. 4a).
It has been reported that inhibition of glycosylation by tunicamycin facilitates TRAIL-R1
transport to the cell surface and overcome resistance to TRAIL [27]. We have examined the
role of TRAIL-R1 in the sensitization of MDA-MB231 cells to TRAIL by tunicamycin. As
shown in Fig. 4b silencing the expression of TRAIL-R1 partially inhibited apoptosis induced
by the combination of tunicamycin and TRAIL. Together, all these results suggest that a
certain amount of heteromeric complexes TRAIL-R1/R2 [28] may be involved in the
induction of apoptosis by TRAIL in ER stressed cells.
The C/EBP homologous protein (CHOP) has a dual role both as an inhibitor of C/EBPs
function and as a transcriptional activator of other genes [29]. CHOP-dependent
transcriptional up-regulation of TRAIL-R2 expression following ER stress has been reported
in different cell types [16, 18]. We explored this issue in MDA-MB231 cells by silencing
CHOP expression with siRNA prior to the activation of ER stress with tunicamycin. As can
be observed in Fig. 5a RNA interference efficiently reduced cellular levels of CHOP protein.
Rather unexpectedly, CHOP silencing did not prevent ER stress-mediated TRAIL-R2 up-
regulation (Fig. 5a), suggesting that the role of this transcription factor in the regulation of
TRAIL-R2 expression upon ER stress could be cell type-dependent.
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It has been reported that the Ire1α/XBP-1 pathway of the UPR plays a certain role in
TRAIL-R2 up-regulation following ER stress by 2-deoxy-D-glucose [20]. To further
elucidate the role of the Ire1α arm of the UPR in the regulation of TRAIL-R2 expression by
ER stress in MDA-MB231 cells Ire1α expression was silenced by RNA interference prior to
ER stress induction with tunicamycin. In Ire1α-depleted cells we assessed the impact of ER
stress on TRAIL-R2 expression. Knockdown of IRE1α did not prevent ER stress-induced
TRAIL-R2 up-regulation as measured either in whole cell lysates (Fig. 5b) or cell surface
expression (not shown).
An important ER stress sensor and UPR mediator is the PKR-like ER kinase (PERK), a
transmembrane protein that is kept in an inactive state through its interaction with the ER
chaperone GRP78/BIP [30]. Upon ER stress, GRP78/BIP dissociates from PERK leading to
activation of this kinase. We examined the role of PERK in the regulation of TRAIL-R2
expression in MDA-MB231 cells treated with tunicamycin. Results shown in Fig. 5c
indicate that silencing PERK expression clearly inhibited PERK signaling as demonstrated
by the reduced phosphorylation of the PERK substrate eIF2α and the inhibition of ER
stress-mediated up-regulation of the transcriptional regulator CHOP. Interestingly,
knockdown of PERK markedly inhibited TRAIL-R2 up-regulation in cells treated with
tunicamycin (Fig. 5c) and significantly reduced cell surface expression (Fig. 5d). The
different effects of PERK silencing on total and cell surface expression of TRAIL-R2 in
tunicamycin-treated cells can be explained by the UPR-independent modulation of TRAIL-
R2 transport to the cell surface following inhibition of protein glycosylation by tunicamycin,
as previously reported [27].
Survival role of GRP78 in TRAIL-induced apoptosis
Under ER homeostasis, the ER chaperone GRP78/BIP directly interacts with all three ER
stress sensors, PERK, ATF6 and IRE1, and keeps them in inactive forms in non-stressed
cells [13, 31]. Upon ER stress, misfolded proteins accumulate in the lumen of the ER and
GRP78 is released from the ER stress sensors. Release from GRP78 allows the activation
and transduction of the unfolded protein signals across the ER membrane to the cytosol and
the nucleus. We reasoned that reducing GRP78 levels by RNA interference should lead to
ER stress and UPR activation. As shown in Fig. 6a, silencing GRP78 expression in MDA-
MB231 cells induced the phosphorylation of the α subunit of eukaryotic translation
initiation factor 2 (eIF2α), a substrate of ER resident PKR-like kinase. Furthermore, GRP78
knockdown also induced CHOP and XBP1s expression, two markers of activated UPR (Fig.
6b). We then determined whether sensitivity to TRAIL was affected in cells in which ER
stress had been induced by GRP78 knockdown. Strikingly, following GRP78 silencing there
was a clear sensitization to TRAIL-induced apoptosis in both MDA-MB231 and HeLa cells
(Fig. 6c). Furthermore, cell death induced by TRAIL in GRP78-depleted cells was
dependent on caspase activation as it was completely inhibited in the presence of the
pancaspase inhibitor Z-VAD-fmk (Fig. 6d).
We next examined whether ER stress induced following GRP78 knockdown affected
TRAIL-R2 levels and TRAIL-induced apoptosis in MDA-MB231 cells. As shown in Fig.
7a, GRP78 silencing also caused an increase in both total and cell surface levels of TRAIL-
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R2. Furthermore, silencing PERK expression partially reduced sensitization to TRAIL in
GRP78-depleted cells (Fig. 7b), suggesting a certain role of TRAIL-R2 up-regulation in the
sensitization to TRAIL in these cells. These results also suggested that other regulators of
apoptosis signaling by TRAIL were probably involved in the sensitization of MDA-MB231
cells to TRAIL by ER stress.
Role of FLIP and Mcl-1 in the sensitization of cells to TRAIL upon ER stress
We have recently reported that simultaneous down-regulation of anti-apoptotic Mcl-1 and
FLIP proteins following treatment of breast tumor cells with microtubules interfering agents
promotes sensitization to TRAIL [22]. To further investigate the mechanisms underlying the
sensitization by ER stress to TRAIL we examined the expression of these anti-apoptotic
proteins in both transformed and nontransformed cells treated with tunicamycin. As can be
observed in Fig. 8a, 15 h-treatment with tunicamycin caused a dose-dependent down-
regulation of FLIP and Mcl-1 proteins in all cell lines. Remarkably, the dose–response of
tunicamycin in the down-regulation of FLIP and Mcl-1 (Fig. 8a) strongly correlated with the
sensitization to TRAIL (Fig. 1) in the various cell lines tested. Likewise, GRP78 knockdown
also induced the down-regulation of Mcl-1 and cFLIP proteins (Fig. 8b), further suggesting
that ER stress is an important regulator of the expression of both anti-apoptotic proteins. To
determine whether down-regulation of these anti-apoptotic proteins in ER stressed cells was
a crucial event in the sensitization to TRAIL, Mcl-1 and FLIP expression were silenced prior
to TRAIL treatment. As shown in Fig. 8c simultaneous knockdown of both cFLIP and
Mcl-1 significantly augmented the sensitization caused by either siRNA alone. These data
further support our hypothesis that down-regulation of cFLIP and Mcl-1 expression by ER
stress is critical for the sensitization of cells to TRAIL-induced apoptosis.
To further assessed the role of cFLIP in the sensitization observed we determined the
sensitizing effect of tunicamycin in TRAIL-induced apoptosis in MDA-MB231 cells over-
expressing cFLIPL. Results shown in Fig. 8d demonstrate that cells over-expressing cFLIPL
were clearly more resistant to ER stress-induced sensitization to TRAIL than cells
expressing normal cFLIP levels. Similarly, sensitization to TRAIL-induced apoptosis
following GRP78 knockdown was significantly reduced in cells over-expressing cFLIPL
(Fig. 8e). In summary, our data indicate that down-regulation of anti-apoptotic proteins
cFLIP and Mcl-1 together with the up-regulation of TRAIL-R2 expression are key events in
the sensitization of ER stressed cells to TRAIL-induced apoptosis.
Discussion
In response to a protein overload in the ER, cells activate the complex signaling of the UPR
to increase the folding capacity of the ER and restore homeostasis. These adaptive
mechanisms are sometimes insufficient to maintain homeostasis in the ER and an apoptotic
cell death process is then induced [32, 33]. Although the activation of the intrinsic apoptotic
pathway has been reported in ER stressed cells [34], a number of evidences support the
involvement of death receptors and in particular TRAIL-R2/DR5 in the death of cells
undergoing ER stress [15–17]. In addition, TRAIL-R2 up-regulation by ER stress treatments
has been suggested to play a prominent role in the sensitization of different tumor cell lines
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to exogenous TRAIL by ER stress treatments [18–20]. However, the molecular mechanisms
of the sensitization to TRAIL have not been fully elucidated. Regarding the mechanism
underlying the up-regulation of TRAIL-R2 expression following ER stress, the involvement
of the transcription factor CHOP has been previously reported [16, 18, 19, 35]. In contrast,
studies in melanoma cells have indicated that stable knockdown of x-box-binding protein-1
(XBP-1) with shRNA inhibited ER stress-induced up-regulation of TRAIL-R2, by a CHOP-
independent mechanism [20]. Ire1-dependent splicing of the XBP-1 mRNA generate the
XBP-1s transcription factor, a potent activator of UPR target genes [36]. Our data indicate
that in MDA-MB231 cells up-regulation of TRAIL-R2 expression and sensitization to
TRAIL upon ER stress occurs through a CHOP and Ire1-independent process. Our results
also demonstrate that ER stress-mediated up-regulation of TRAIL-R2 was inhibited by
blocking the ER stress transducer PERK by RNA interference. Although the axis ATF4-
CHOP is an important signaling pathway in the PERK arm of the UPR, it is known that
approximately half of the PERK-dependent UPR target genes are ATF4-independent [37],
suggesting that other PERK effectors should be involved in the regulation of TRAIL-R2
expression in MDA-MB231 cells. In mammalian cells, the three ER transmembrane
components, IRE1, PERK, and ATF6, initiate distinct UPR signaling branches and display
distinct sensitivities toward different forms of ER stress [38]. Moreover, cross-talking and
functional redundancy are important characteristic of the three arms of the UPR [13].
Furthermore, there are marked differences in terms of tissue-specific regulation of the UPR
[39]. Taken together, these features of the UPR may explain the differences between our
results and others in term of the regulation by ER stress of TRAIL-R2 expression.
Despite a reduction in TRAIL-R2 expression in PERK-silenced cells following ER stress,
sensitization to TRAIL-induced apoptosis was only partially reduced. These results
suggested that other apoptosis regulators of TRAIL signaling should be also modulated by
ER stress. In this respect, we observed a decreased expression of FLIP and Mcl-1 in
different cell lines undergoing ER stress. There are conflicting results on the role of Mcl-1 in
the resistance of cells to TRAIL. Down-regulating Mcl-1 expression has been reported to
sensitize tumor cells to TRAIL-induced apoptosis [40, 41]. However, our previous results
indicated that Mcl-1 knockdown by RNA interference only weakly facilitated activation of
apoptosis by TRAIL in MDA-MB231 cells [22]. Taken together, these data suggest that
involvement of Mcl-1 in the resistance of cells to TRAIL might be cell type-dependent.
Interestingly, simultaneous down-regulation of Mcl-1 and cFLIP significantly enhanced
sensitization to apoptosis, suggesting the cooperation between Mcl-1 and cFLIP in the
mechanism of cell resistance to TRAIL [22]. On the other hand, down-regulation of FLIP is
sufficient to sensitize tumor cells to TRAIL [12, 42, 43]. Mcl-1 and cFLIP are short half-life
proteins which are subject to constitutive polyubiquitination and subsequent degradation by
the proteasome [44, 45]. It has been demonstrated that c-Jun N-terminal kinase (JNK)
activation by TNF-α reduces cFLIPL stability by a mechanism involving the JNK-mediated
phosphorylation and activation of the E3 ubiquitin ligase Itch, which ubiquitinates cFLIPL
and induces its proteasomal degradation [46]. Although in ER-stressed cells JNK could be
activated by the Ire1/TRAF2/Ask1 pathway [47], our unpublished results indicate that
silencing Ire1 expression by RNA interference did not prevent ER stress-induced FLIP
down-regulation. However, we can not exclude a role of the JNK/Itch pathway in the down-
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regulation of FLIP observed in our studies as it has been recently reported that ER stress
induced by a vitamin E derivative down-regulates FLIPL expression through a TRAIL-R2/
JNK-dependent Itch E3 ligase-mediated ubiquitination and degradation by the proteasome
[48]. Proteasome-mediated degradation of Mcl-1 is regulated by phosphorylation [49]. It has
been proposed that JNK could be responsible for the priming phosphorylation of Mcl-1
necessary for the docking of GSK-3 to Mcl-1 [50]. On the other hand, Mcl-1 is a target for
the BH3-containing E3 ubiquitin ligase Mule [51]. It remains to be determined whether the
proteasome-mediated degradation of Mcl-1 through the JNK/GSK-3/Mule pathway is also
involved in the down-regulation of Mcl-1 in ER stressed cells.
GRP78 is a major ER chaperone involved in protein folding and assembly and a key
regulator of the UPR. Our data show for the first time that silencing GRP78 expression by
RNA interference activates the UPR and markedly sensitizes cells to TRAIL further
supporting the anti-apoptotic function of GRP78. We also demonstrate that TRAIL-R2 up-
regulation and down-regulation of FLIP and Mcl-1 induced by GRP78 knockdown are
important events in the sensitization to TRAIL. Several evidences have shown that GRP78
can also be present outside the ER [52]. In tumor cells, GRP78 is frequently overexpressed
at the cell surface where it could bind to various extracellular ligands to result either in cell
death or cell survival [17, 53]. In this respect, it has been recently reported that prostate
apoptosis response-4 (PAR-4) activates an extrinsic pathways for apoptosis upon binding to
GRP78 at the cell surface [17]. In contrast to these results, our data support a survival role of
GRP78 preventing the activation of apoptosis by TRAIL. Differences in the cell surface
levels of GRP78 may explain these apparently discrepant results, with cells expressing low
levels of GRP78 being more resistant to TRAIL. In these cells, ER stress induced by GRP78
down-regulation would activate the pro-apoptotic UPR and sensitize cells to TRAIL.
The findings that different tumor cells can be sensitized to TRAIL by agents that induce ER
stress have lead other authors to suggest that these treatments could be potential antitumor
therapies in combination with TRAIL [18–20]. However, our data also demonstrate that not
only tumor cell lines but also nontransformed cells are markedly sensitized to TRAIL-
induced apoptosis by ER stress. In the nontransformed cell lines, TRAIL-R2 up-regulation
and down-regulation of FLIP and Mcl-1 are also observed, suggesting that these changes in
apoptosis-related proteins belong to a preemptive response of mammalian cells to ER stress.
These results imply that targeting ER stress could also affect the sensitivity of normal cells
to TRAIL and hence this therapeutic strategy may not be acceptable. On the other hand,
tumor cells are often subject to ER stress in vivo. Tumor microenvironment is characterized
by glucose deprivation, acidosis, and severe hypoxia. These combined factors leads to the
accumulation of misfolded proteins in the ER, triggering the UPR to facilitate tumor
survival and growth [14]. Besides the survival role of the UPR, our in vitro results suggest
that activating the UPR in tumors by microenvironmental cues may modulate the expression
of proteins of the extrinsic pathway of apoptosis, like TRAIL-R2, FLIP and Mcl-1,
sensitizing these cells to TRAIL. This may contribute to explain the differential sensitivity
of normal and cancer cells to intraperitoneally administered TRAIL observed in in vivo
studies [54, 55].
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Collectively, our data reveal a pleiotropic mechanism involving both apoptotic and anti-
apoptotic proteins for the sensitizing effect of ER stress on the regulation of TRAIL
receptor-mediated apoptosis in both transformed and non-transformed cells. These data
further highlight the central role of the UPR to maintain protein folding homeostasis and to
facilitate the activation of the extrinsic apoptotic pathway when homeostasis can not be
restored following sustained ER stress. As we show that ER stress also sensitizes
nontransformed cells to TRAIL, a more complete understanding of how UPR does this
could provide insights into the role of UPR signaling in normal physiology and regulation of
TRAIL action.
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Fig. 1.
ER stress sensitizes both transformed and nontransformed cells to TRAIL-induced
apoptosis. a MDA-MB231 cells (upper panels) were treated for 15 h with a range of
concentrations of tunicamycin or thapsigargin prior to incubation in the presence or absence
TRAIL (500 ng/ml) for 6 h. Apoptosis was assessed as described under “Materials and
methods” section. Error bars represent S.D. from three different experiments. Lower panels
show a picture of apoptotic and non-apoptotic cells in untreated cultures (UT) or cultures of
MDA-MB231 cells treated as indicated. b Activation of the UPR was determined by
immunoblotting (CHOP) or RT-PCR (XBP1s) after 15 h-treatment with tunicamycin or
thapsigargin. GAPDH was used as a protein loading control. RT-PCR product of β-actin was
used as a control for mRNA input. Results are representative of at least two independent
experiments. c Hypodiploid cells were determined in HeLa (upper panel) or MM.1S (lower
panel) cell cultures treated as described in a. Error bars represent S.D. from three different
experiments. d MDA-MB231 cells were treated for 15 h with tunicamycin (250 ng/ml) prior
to incubation with or without Z-VAD-fmk (50 μM) in the presence or absence TRAIL (500
ng/ml) for 6 h. Apoptosis was assessed as described under “Materials and methods” section.
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Error bars represent S.D. from three different experiments. Induction of apoptosis in RPE1
(e) and MCF-10A (f) cells treated as described in a. Error bars represent S.D. from three
different experiments. Activation of the UPR was determined by western blot analysis of
GRP78 expression (RPE1) and eIF2α phosphorylation (MCF-10A)
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Fig. 2.
DISC formation and activation of a mitochondria-operated pathway of apoptosis by TRAIL
in ER stressed cells. a MDA-MB231 cells were incubated with tunicamycin (250 ng/ml) for
15 h prior to treatment with TRAIL (500 ng/ml) for 4 h. Caspase-8 activation, Bid cleavage,
caspase-9 processing, caspase-3 activation and PARP-1 cleavage were assessed by
immunoblotting. GAPDH was used as a protein loading control. Results are representative
of at least two independent experiments. b MDA-MB231 were transfected with 50 nM of
either Bid or scrambled (control) siRNA for 48 h as described in “Materials and methods”
section. After this incubation cells were treated with or without tunicamycin for 15 h prior to
incubation with or without TRAIL (500 ng/ml) for 6 h and apoptosis was determined as
percentage of subG1 cells. Error bars represent S.D. from three independent experiments.
*P <0.05 as compared with scrambled siRNA. Immunoblot analysis was also performed in
siRNA transfected cells to verify protein knockdown. c MDA-MB231 cells were either
treated or not with tunicamycin (250 ng/ml) for 15 h before the incubation with biotin-
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labelled TRAIL (bTRAIL, 1 μg/ml) for 30 min. Unstimulated receptor controls (u/s)
represent the addition of bTRAIL to an equivalent volume of lysate isolated from TRAIL-
unstimulated cells. DISC was isolated as described in “Materials and methods” section, and
its components TRAIL-R2, caspase-8 and FADD, analyzed by western blotting. Lysates are
included as a positive control for the expression of these proteins in MDA-MB231 cells.
Data shown are representative of three independent experiments
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Fig. 3.
ER stress induces TRAIL-R2 up-regulation in both transformed and nontransformed cells.
Breast tumor cells MDA-MB231 were treated with the different ER stress inducers at the
indicated concentrations for 15 h. TRAIL-R2 protein (a) and mRNA (b) levels were
determined by immunoblotting and RT-PCR, respectively. c Nontransformed cells were
incubated for 15 h in the presence or absence of the indicated concentrations of tunicamycin
and TRAIL-R2 protein expression was assessed by western blot. d Nontransformed (RPE1)
and transformed (MDA-MB231) cells were incubated for 15 h in the absence or presence of
tunicamycin (250 ng/ml). Cell surface expression of TRAIL-R2 was determined by flow
cytometry as described in “Materials and methods” section. Data shown are representative
of three independent experiments
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Fig. 4.
TRAIL-R2 plays a major role in apoptosis induced by TRAIL in ER stressed cells. MDA-
MB231 cells were transfected with 50 nM TRAIL-R2 (a), TRAIL-R1 (b) or scrambled
(control) siRNA (a, b) for 48 h prior to incubation in the absence or presence of tunicamycin
(250 ng/ml) for 15 h. After this incubation cells were treated with or without TRAIL (500
ng/ml) for 6 h and apoptosis was determined as described in “Materials and methods”
section. Error bars represent S.D. from three independent experiments. Protein knockdown
was assessed by western blotting and GAPDH was used as a control for protein loading.
Results are representative of at least three independent experiments
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Fig. 5.
ER stress up-regulates TRAIL-R2 through a PERK-dependent, CHOP and Ire1-independent
mechanism. MDA-MB231 cells were transfected with scrambled (c) or CHOP (a), IRE1α
(b) or PERK (c, d) siRNAs for 48 h to silence protein expression. Transfected cells were
then treated with tunicamycin for 15 h prior to the analysis of protein knockdown and
TRAIL-R2 expression by western blotting (a, b, c) or cell surface levels of TRAIL-R2 by
flow cytometry (d). Results are representative of at least three independent experiments
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Fig. 6.
GRP78 knockdown activates the UPR and sensitizes cells to TRAIL-induced apoptosis. a
Cell lysates from MDA-MB231 cells transfected with siRNAs (50 nM) for 48 h were
analyzed for protein expression as described in “Materials and methods” section. b MDA-
MB231 cells were transfected with 50 nM GRP78 siRNA or a scrambled (control) siRNA
for 48 h as described in “Materials and methods” section. XBP1s and CHOP mRNA levels
were determined by RT-PCR and β-actin was used as a control for mRNA input. Results are
representative of at least two independent experiments. c MDA-MB231 or HeLa cells were
transfected with siRNAs for 48 h and treated with TRAIL (500 ng/ml) for 24 h. Apoptosis
was assessed as the percentage of hypodiploid cells. Error bars represent S.D. from three
independent experiments. *P <0.05, **P <0.01. d MDA-MB231 cells transfected with
siRNAs (50 nM) for 48 h were incubated with or without TRAIL for 24 h in the presence or
absence of Z-VAD-fmk. Hypodiploid cells were determined as described under “Materials
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and methods” section. Error bars represent S.D. from three independent experiments. **P
<0.01
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Fig. 7.
GRP78 knockdown up-regulates TRAIL-R2 expression and sensitizes cells to TRAIL-
induced apoptosis through a PERK-dependent mechanism. a Cell lysates from MDA-
MB231 cells transfected with siRNAs (50 nM) for 48 h were analyzed for protein
expression by western blotting (upper panel) or cell surface expression by flow cytometry
(lower panel) as described in “Materials and methods” section. b MDA-MB231 were
transfected with siRNAs for 48 h and treated with TRAIL (500 ng/ml) for 24 h. Apoptosis
was assessed as the percentage of cells with sub-G1 DNA content. Error bars represent S.D.
from three independent experiments. * Indicate a statistically significant difference in
sensitivity to TRAIL when comparing GRP78 siRNA-transfected cells with cells transfected
with GRP78/PERK siRNAs. (P <0.05)
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Fig. 8.
Role of FLIP and Mcl-1 in ER-induced sensitization to TRAIL. a Cells were treated for 15 h
with the indicated concentrations of tunicamycin and protein expression was determined in
cell lysates by western blotting with specific antibodies. b MDA-MB231 or HeLa cells were
transfected with 50 nM GRP78 siRNA or a control siRNA for 48 h as described in
“Materials and methods” section. Cell lysates from transfected cells were analyzed for
protein expression. Results are representative of at least three independent experiments. c
MDA-MB231 cells were transfected with siRNAs for 48 h and treated with TRAIL (500
ng/ml) for 6 h. Apoptosis was assessed as the percentage of hypodiploid cells. Error bars
represent S.D. from three independent experiments. Cell lysates from MDA-MB231 cells
transfected with siRNAs (50 nM) for 48 h were analyzed for protein expression as described
in “Materials and methods” section. d Mock-transfected and MDA-MB231 cells transfected
with the pCR3.V64-Met-Flag-FLIPL vector were treated with or without tunicamycin (250
ng/ml) for 15 h prior to the incubation with or without TRAIL (500 ng/ml) for 6 h. Protein
expression was determined by western blotting (left panel). Apoptosis was measured as the
percentage of cells with sub-G1 DNA content (right panel). Error bars represent S.D. from
three independent experiments. ***P <0.001. e Mock or FLIPL-overexpressing MDA-
MB231 cells were transfected with siRNAs (50 nM) for 48 h and then treated with TRAIL
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for 24 h. Apoptosis was assessed as the percentage of cells with sub-G1 DNA content. Error
bars represent S.D. from three independent experiments. *P <0.05
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